Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(3-Chlorophenyl)-2-oxopropanoic acid is a diastereomer of 2-phenylpropanoic acid. It is used in the synthesis of diketopiperazines, which are analogues of amphetamines. The synthesis proceeds by the addition of ethyl chloroacetate to α-chloroacrylic acid followed by reaction with cyclohexanol and then reduction with lithium aluminum hydride. The stereoselectivity of this reaction is determined by the enantioselective transfer of a proton from the hydroxyl group to the adjacent carbonyl group. This process occurs more readily when an enantiomerically pure chiral catalyst is used, leading to a diastereoselective synthesis.</p>

<p>Ethyl 4-phenylbut-2-ynoate is a drug that has been shown to have an inhibitory effect on cancer cells. It belongs to the class of pharmacological agents, which are agents for treating diseases. Ethyl 4-phenylbut-2-ynoate is used to treat certain cancers, including breast cancer and non-small cell lung cancer. This drug also inhibits histone deacetylase activity, thereby preventing transcription. The clinical use of this drug is limited due to its low bioavailability. Pharmacokinetic studies have shown that this drug is eliminated rapidly after administration and has a short half life of approximately 1 hour. There are no known regulatory proteins for this drug or any modifications in its fatty acids or phenotype.</p>

<p>8-(Benzyloxy)imidazo[1,2-a]pyridine is a potent and selective bradykinin B2 receptor antagonist. It is an orally active compound that has been found to be absorbed in the gastrointestinal tract. 8-(Benzyloxy)imidazo[1,2-a]pyridine has shown antagonistic activities against bradykinin B2 receptors by binding to the receptor’s nucleophilic site. This binding causes a conformational change in the receptor, preventing it from being activated. 8-(Benzyloxy)imidazo[1,2-a]pyridine also has a high affinity for the bradykinin B2 receptor and can be used as an organocatalyst in organic chemistry reactions.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Benzyl-4-(hydroxymethyl)pyrrolidin-2-one is an experimental analgesic drug. It is a prodrug that undergoes several metabolic transformations, including oxidation, hydroxylation, and reduction to form the active metabolite 1-benzylpyrrolidin-2(3H)-one. This compound has been shown to have potent antihypertensive effects in animals as well as antidepressant activity. The optical isomer of this compound has also been shown to have anticonvulsant effects in animals.</p>